Post Scrip: The ASPL Pharmacy Law Podcast
Post-Scrip is the podcast of The American Society for Pharmacy Law. ASPL is an organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties. ASPL is a non-profit which encourages diversity & inclusion with the Society, regardless of differing backgrounds, perspectives, experiences, orientations, origins, and practice settings. The Society embraces participation and diversity as it leads to advancing our purpose: Furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues; Communicating accurate legal educational information; and Providing educational opportunities for pharmacists, attorneys, and others who are interested in pharmacy law.
Post Scrip: The ASPL Pharmacy Law Podcast
S4E2 - Pharmacists Aren't the Telemedicine Police with Mark Boesen, PharmD, JD
In this episode of Post-Script, Henry introduces Mark Boesen, PharmD, JD, founding partner of Boesen and Snow law firm. They discuss Mark's upcoming presentation "Pharmacists Aren't Telemedicine Police, But You Will Be Treated Like You Are." This presentation will address the growing regulatory scrutiny facing pharmacies dispensing telemedicine prescriptions, as state regulators, medical boards, and the DEA increasingly target pharmacies instead of directly addressing prescriber compliance concerns.
Mark shares his unique 30-year journey from pharmacy practice to working for Senator John McCain, building specialty pharmacy operations at what would become Avella, and eventually founding his law firm. He discusses how his extensive pharmacy experience provides practical operational insights alongside legal expertise for his clients.
The conversation explores how telemedicine prescriptions are receiving the same scrutiny as controlled substance prescriptions, creating double jeopardy when the two overlap. Mark explains his approach of providing attendees with practical resources including sample policies, procedures, and documentation strategies developed from his extensive regulatory encounters. He discusses his firm's evolution from traditional regulatory compliance work to federal litigation, particularly around compounding, telemedicine, and GLP-1 drug issues.
Mark also touches on his background in substance abuse treatment and prevention from his time as Executive Director of the Maine Association of Substance Abuse Programs, highlighting the unique drug trafficking challenges Maine faces due to its extensive coastline and fishing industry.
Join us at the annual conference: Developments in Pharmacy Law Seminar, November 6-9, 2025 at the Westin on the beach in Fort Lauderdale, Florida.